Alliances
NBE-Therapeutics AG and SOTIO a.s. today announced that SOTIO has elected a second target for the development of a next generation antibody-drug conjugate under their existing license and collaboration agreement.
Collaboration aims to evaluate the potential of microbiome-derived antigens that mimic tumor antigens and neoantigens (“onco-mimics”) to induce anti-tumor immune responses
New technology reduces amount of time spent preparing treatment plans in cancer genomic medicine by half in verification trials conducted with the Department of Hematology and Oncology
Both Owlstone and Thermo Fisher will work together to integrate Thermo Fisher’s Orbitrap gas chromatography mass spectrometry instrumentation into Owlstone Medical’s Breath Biopsy platform.
Enterome and Memorial Sloan Kettering Cancer Center have teamed up to evaluate the potential of gut microbiome-derived antigens for development as potential cancer immunotherapies.
Under the new deal, Artios Pharma licensed rights to research, develop, manufacture and commercialize products globally from a small-molecule ATR inhibitor program that was jointly developed by MD Anderson and ShangPharma.
Vifor picks up external R&D capabilities for its own nephrology pipeline and Evotec gains a commercial partner via outlicensing all kidney disease assets that are developed from the joint venture.
AstraZeneca is significantly expanding its footprint in China with the establishment of a global research and development center in the country, as well as the launch of a $1 billion fund aimed at supporting that nation’s healthcare sector.
A*STAR’s Institute of Bioengineering and Nanotechnology has teamed up with the Singapore Institute of Advanced Medicine Holdings Pte Ltd to explore how to better tackle nasopharyngeal carcinoma, a type of head and neck cancer, through targeted proton therapy.
They announced an exclusive license deal and research agreement to develop cord-blood derived chimeric antigen receptor-directed natural killer (CAR NK)-cell therapies.
PRESS RELEASES